Basic Information
Enzolytics is a drug development company dedicated to using its proprietary proteins for the treatment of debilitating infectious diseases, creating medications that improve human health. Enzolytics, Inc.'s flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown to be effective in treating HIV. ITV-1 has been proven to modulate the immune system. IPF is a platform technology with potential for widespread application. It does not exhibit the major neurological, gastrointestinal, and hematological side effects found in currently used antiretroviral drugs. IPF has not demonstrated antiviral resistance and is cost-effective.